Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

IBP vs TMHC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TMHC Captures Overall Composite Edge (50.7 HOLD vs 41.7 SELL), While IBP Leads 4–2 on Growth & Valuation Pillars

TMHC Overall Winner 6-Pillar Tally: IBP 4 – 2 TMHC Matrix Metrics: IBP 3 – 7 TMHC

As of Nov 20, 2026, Taylor Morrison Home Corporation (TMHC) captures the overall head-to-head institutional edge over Installed Building Products, Inc. (IBP) on higher Unified Composite conviction (50.7/100 HOLD vs. 41.7/100 SELL) after splitting the core matrix 7–3 (led by Valuation Multiples, Options & Positioning), while IBP wins 4–2 across the 6-pillar growth and valuation breakdown. IBP trades at $221.42 (21.3x Forward P/E, 11.9% operating margin) versus TMHC at $72.45 (11.3x Forward P/E, 11.1% operating margin).

  • Growth vs. Quality Trade-Off: TMHC earns the overall head-to-head edge with a stronger Unified Composite Score (50.7/100 HOLD vs. IBP 41.7/100 SELL) and 0.79β · 3% Vol risk profile, whereas IBP leads top-line expansion (+3.9% YoY revenue growth, 1.20x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IBP vs TMHC
IBP NYSE
Installed Building Products, Inc.
General Bldg Contractors - Residential Bldgs
$221.42
-0.29% 1D
Market Cap $6.2B
TTM Revenue $2.99B
Forward P/E 21.3x
Beta / 30D Vol 1.33β · 64% Vol
Unified Composite Score
41.7 / 100 SELL
Tech 38.0 Fund 44.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 53.4 · SMA20: $219.02 · SMA50: $203.68
TMHC NYSE Head-to-Head Winner
Taylor Morrison Home Corporation Common Stock
Operative Builders
$72.45
-0.03% 1D
Market Cap $6.6B
TTM Revenue $7.61B
Forward P/E 11.3x
Beta / 30D Vol 0.79β · 3% Vol
Unified Composite Score
50.7 / 100 HOLD
Tech 40.0 Fund 45.0 Flow 56.0 Mom 36.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.0% over 20 days), RSI 75
RSI-14: 74.5 · SMA20: $72.00 · SMA50: $68.09

6-Pillar Scorecard Institutional Category Breakdown (IBP 4 – 2 TMHC)

Columns: Metric · IBP · TMHC
1. Valuation Multiples TMHC
Forward P/E 21.3x 11.3x
Trailing P/E 25.3x 10.8x
PEG Ratio 1.20x 1.41x
EV / Revenue 2.1x 1.1x
2. Growth & Scale IBP
Revenue Growth (YoY) +3.9% -26.8%
Earnings Growth (YoY) -18.2% -51.2%
TTM Revenue (USD) $2.99B $7.61B
Market Cap $6.2B $6.6B
3. Profitability & Quality IBP
Gross Margin 33.1% 22.6%
Operating Margin 11.9% 11.1%
Net Profit Margin 7.9% 8.8%
Return on Equity (ROE) 34.3% 11.1%
4. Balance Sheet & Cash Flow IBP
Cash Generation (TTM) $470M EBITDA $688M
Cash Flow Margin 15.7% EBITDA Mgn 9.0%
Net Cash / Leverage $26.36 Book/Sh · 34.3% ROE $1.76B Net Debt (0.39x D/E)
Dividend Yield 0.66% None (0.00%)
5. Options & Positioning TMHC
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 44.5% (1st %ile) 0.2% (<1st %ile)
Put/Call OI Skew N/A 0.02x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat IBP
OpEx & R&D Intensity 21.2% of Rev ($635M) 11.5% of Rev ($875M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Residential Construction Operator Residential Construction Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IBP (3) vs TMHC (7)
Institutional Metric IBP TMHC Criterion Row Edge
Market Capitalization
Scale
$6.2B $6.6B Larger Scale TMHC
Trailing P/E Ratio
Valuation
25.3x 10.8x Lower Multiple TMHC
Forward P/E Ratio
Valuation
21.3x 11.3x Lower Multiple TMHC
Revenue Growth (YoY)
Growth
+3.9% -26.8% Higher Growth IBP
Operating Margin (TTM)
Profitability
11.9% 11.1% Higher Margin IBP
Net Profit Margin
Profitability
7.9% 8.8% Higher Margin TMHC
Return on Equity (ROE)
Capital Efficiency
34.3% 11.1% Higher ROE IBP
52-Week Range Position
Momentum
26% ($176–$349) 100% ($54–$72) Stronger Trend TMHC
Beta / 30D Volatility
Risk Regime
1.33β · 64% Vol 0.79β · 3% Vol Lower Realized Risk TMHC
Unified Institutional Score
Composite Signal
41.7 / 100 (SELL) 50.7 / 100 (HOLD) Higher Composite TMHC
Trailing 12M Revenue (USD)
Operating Scale
$2.99B $7.61B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
33.1% 22.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.20x PEG · 2.1x EV/Rev 1.41x PEG · 1.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$470M EBITDA ($26.36 Book/Sh · 34.3% ROE) $688M ($1.76B Net Debt (0.39x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IBP +4.67 pp
IBP: +5.79% · TMHC: +1.12%
3M Horizon TMHC +38.67 pp
IBP: -27.21% · TMHC: +11.46%
6M Horizon TMHC +39.79 pp
IBP: -27.22% · TMHC: +12.57%
1Y Horizon TMHC +34.0 pp
IBP: -9.22% · TMHC: +24.78%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IBP vs TMHC. Trailing 12-month operating profitability (IBP 11.9% vs TMHC 11.1%) and valuation multiples (IBP 21.3x vs TMHC 11.3x Forward P/E) are benchmarked directly in Pillar 4 below.

IBP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.99B
Gross Margin33.1%
Op. Margin11.9%
ROE / Fwd P/E34.3% · 21.3x
TMHC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$7.61B
Gross Margin22.6%
Op. Margin11.1%
ROE / Fwd P/E11.1% · 11.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IBP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 44.5%
IV Percentile 1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IBP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TMHC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 0.2%
IV Percentile <1st %ile
Put/Call OI Skew 0.02x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact TMHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IBP Moat Profile Scale & Operating Efficiency Moat
Residential Construction Operator
Competes within the Residential Construction value chain with $6.2B market capitalization and 11.9% operating margin.
OpEx & R&D Reinvestment 21.2% of Rev ($635M)
90D Engineering Disclosures 0 Published
TMHC Moat Profile Cyclical / Execution-Driven Positioning
Residential Construction Operator
Competes within the Residential Construction value chain with $6.6B market capitalization and 11.1% operating margin.
OpEx & R&D Reinvestment 11.5% of Rev ($875M)
90D Engineering Disclosures 0 Published

Investor FAQ IBP vs TMHC Key Questions & Quantitative Answers

As of Nov 20, 2026, Taylor Morrison Home Corporation (TMHC) captures the overall head-to-head institutional edge over Installed Building Products, Inc. (IBP) on higher Unified Composite conviction (50.7/100 HOLD vs. 41.7/100 SELL) after splitting the core matrix 7–3 (led by Valuation Multiples, Options & Positioning), while IBP wins 4–2 across the 6-pillar growth and valuation breakdown. IBP trades at $221.42 (21.3x Forward P/E, 11.9% operating margin) versus TMHC at $72.45 (11.3x Forward P/E, 11.1% operating margin). Growth vs. Quality Trade-Off: TMHC earns the overall head-to-head edge with a stronger Unified Composite Score (50.7/100 HOLD vs. IBP 41.7/100 SELL) and 0.79β · 3% Vol risk profile, whereas IBP leads top-line expansion (+3.9% YoY revenue growth, 1.20x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.

IBP leads the Growth & Scale pillar: IBP posts +3.9% YoY revenue growth and -18.2% YoY earnings growth on $2.99B TTM revenue (33.1% gross margin, 11.9% operating margin), compared with TMHC at -26.8% YoY revenue growth and -51.2% YoY earnings growth on $7.61B TTM revenue (22.6% gross margin, 11.1% operating margin). On trailing 12-month operating scale, IBP generates $2.99B in USD-normalized revenue versus $7.61B for TMHC. In operating R&D and SG&A reinvestment, IBP deploys 21.2% of Rev ($635M) (0 90-day corporate R&D disclosures) versus 11.5% of Rev ($875M) (0 disclosures) for TMHC.

TMHC screens cheaper on headline valuation multiples. IBP trades at 21.3x Forward P/E, 25.3x Trailing P/E, 1.20x PEG, and 2.1x EV/Revenue (15.7% EBITDA margin), whereas TMHC trades at 11.3x Forward P/E, 10.8x Trailing P/E, 1.41x PEG, and 1.1x EV/Revenue (9.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IBP (34.3% ROE) versus TMHC (11.1% ROE) capital efficiency.

In options market volatility and institutional positioning, IBP carries 44.5% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.33β · 64% Vol realized risk). By comparison, TMHC carries 0.2% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.79β · 3% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.